Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00089076
Status:
TERMINATED
Last Update Posted:
2014-05-30
First Post:
2004-08-04
Brief Title:
MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Adult Grade III Lymphomatoid Granulomatosis |
| B-cell Chronic Lymphocytic Leukemia |
| Cutaneous B-cell Non-Hodgkin Lymphoma |
| Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue |
| Intraocular Lymphoma |
| Nodal Marginal Zone B-cell Lymphoma |
| Recurrent Adult Burkitt Lymphoma |
| Recurrent Adult Diffuse Large Cell Lymphoma |
| Recurrent Adult Diffuse Mixed Cell Lymphoma |
| Recurrent Adult Diffuse Small Cleaved Cell Lymphoma |
| Recurrent Adult Grade III Lymphomatoid Granulomatosis |
| Recurrent Adult Hodgkin Lymphoma |
| Recurrent Adult Immunoblastic Large Cell Lymphoma |
| Recurrent Adult Lymphoblastic Lymphoma |
| Recurrent Grade 1 Follicular Lymphoma |
| Recurrent Grade 2 Follicular Lymphoma |
| Recurrent Mantle Cell Lymphoma |
| Recurrent Marginal Zone Lymphoma |
| Refractory Hairy Cell Leukemia |
| Small Intestine Lymphoma |
| Splenic Marginal Zone Lymphoma |
| Testicular Lymphoma |
| Waldenström Macroglobulinemia |
Keywords: